Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study

Fig. 2

Clinical course of patients in CP transfusion group and cumulative survival analysis. (A) Fourteen patients received the initial convalescent plasma transfusion in the intensive care unit. Three patients died within 28 days after the initial transfusion. (B) Cumulative survival incidence was calculated by K-M survival analysis. No significant difference was detected between the two groups with or without CP transfusion (Log-rank P = 0.321)

Back to article page